• English
    • Persian
  • English 
    • English
    • Persian
  • Login
View Item 
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Etiology and antimicrobial susceptibility pattern of pathogenic bacteria in children subjected to UTI: A referral hospital-based study in northwest of Iran

Thumbnail
View/Open
medi-94-e1606.pdf (200.4Kb)
Date
2015
Author
Rezaee, MA
Abdinia, B
Metadata
Show full item record
Abstract
Urinary tract infection (UTI) is 1 of the most common bacterial diseases in children with a considerable resistance to antimicrobials. This 5 years prospective study was carried out to determine the frequency of isolation and antimicrobial resistance patterns of uropathogens among children subjected to urine culture at Tabriz Children Educational-Health Care Center, in the northwest of Iran. Organisms were isolated using standard culture techniques. Frequency of UTI among children examined by urine culture was 3.6%. The isolated bacteria were Escherichia coli (71.4%), followed by Klebsiella spp. (9.6%), Enterococcus spp. (6.4%), Pseudomonas aeruginosa (4.2%), Serratia spp. (4.2%), and Enterobacter spp. (4.2%). E coli resistance levels were 11% for nitrofurantoin, 15% for ciprofloxacin, 25% for nalidixic acid, and 30% to 75% for amikacin, gentamicin, ceftriaxone, ceftizoxime, cefotaxime, and co-trimoxazole. Among the tested antibiotics, ciprofloxacin, showed the highest activity (100%) against Klebsiella and P aeruginosa isolates followed by amikacin, nalidixic acid, and gentamicin. Overall, the highly active antibiotic against Gram-negative and Gram-positive organisms was amikacin and then ciprofloxacin. On the other hand, the empirical initial therapy with co-trimoxazole and third-generation cephalosporins would be inadequate for more cases of UTI in the study area. Moreover, susceptibility testing should be carried out on all clinical isolates, and the empirical antibiotic treatment changed accordingly. Copyright é 2015 Wolters Kluwer Health, Inc. All rights reserved.
URI
http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54085
Collections
  • Published Articles

Related items

Showing items related by title, author, creator and subject.

  • Measurement and comparison of inpatient antibiotic use in five different hospitals in Tabriz 

    Ghaffary, S; Entezari-Maleki, T; Abdollahpour, J; Hamishehkar, H (2017)
    Background: There is a relation between amounts of antibiotic uses and creation of resistant bacteria. Due to the critical role of antibiotics and increasing trend of resistance in developing countries, comprehensive methods ...
  • Drug utilization evaluation of vancomycin in a teaching hospital in Tabriz-Iran 

    Hamishehkar, H; Ebrahimi, D; Mahmoodpoor, A; Mashayekhi, S; Asgharian, P; Reazee, H (2015)
    Background: Drug Utilization Evaluation (DUE) studies are designed to evaluate drug usage appropriateness. In this study we evaluated the relevant use of vancomycin in a teaching hospital in Iran. The results of this study ...
  • Detection of Escherichia coli pathotypes from the cases of diarrhea 

    Zarringhalam, M; Goudarzi, H; Nahaei, MR; Bandehpour, M; Shahbazi, G (2016)
    Escherichia coli is a member of the normal microbiota, and also a common inhabitant of the human and warm-blooded animal intestinal tract, which several pathogenic types of it can cause different diseases. One hundred and ...

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

All of KR-TBZMEDCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV